Back to Results
First PageMeta Content
Cell biology / Developmental biology / Peter Zandstra / Cell therapy / Induced pluripotent stem cell / McEwen Centre for Regenerative Medicine / Regenerative medicine / Biology / Stem cells / Biotechnology


Spring[removed]The CCRM Niche Enable. Integrate. Engage.
Add to Reading List

Document Date: 2012-05-09 12:09:06


Open Document

File Size: 1,34 MB

Share Result on Facebook

City

Montreal / Vancouver / Toronto / Boston / London / /

Company

Agilent Technologies / Cellular Dynamics International / Translation Advisory Group / Medisca Pharmaceuticals / Merck KGaA / STEMCELL Technologies / Axcelon Biopolymers Corp. / Octane Biotech Inc. / Northern Therapeutics Inc. / Stem Cell Therapeutics Corp. / TEVA Innovative Ventures / GE Healthcare / Athersys Inc. / VistaGen Therapeutics Inc. / Google / Interface Biologics Inc. / Cellular Therapies Manufacturing / Pall Corporation / CCRM CCRM / CCRM / CTV / Stem Cell Biology Laboratory / GE Healthcare Life Sciences / Moody's Investors Service / Inc / Contact CCRM Stacey Johnson / Cell Technologies / /

Country

Canada / Scotland / United States / /

Currency

USD / /

/

Event

Natural Disaster / Credit Rating / /

Facility

Ottawa Hospital Research Institute / University of British Columbia / Hospital Research Institute Paul Santerre / Cancer Research Institute / Stem Cell Biology Laboratory / University of Stirling / University Health Network / McMaster University / King’s College / Queen’s University / Sick Children Research Institute / Institute of Biomaterials / Lund Stem Cell Center / The Hospital / University of Toronto Peter Zandstra / Ontario Human iPSC facility / Samuel Lunenfeld Research Institute / University of Toronto / Sinai Hospital / /

IndustryTerm

media relations / pharmaceutical research / biomaterials technology / regenerative medicine network / cell-based technologies / iPSC cell bank / banking / therapeutic applications / /

MedicalTreatment

cell therapy / /

Organization

Sinai Hospital / Institute of Biomaterials and Biomedical Engineering / Samuel Lunenfeld Research Institute / Centre for Commercialization of Regenerative Medicine / McEwen Centre for Regenerative Medicine / Institute of Biomaterials / Cancer Research Institute / UK Gene Therapy Advisory Committee / CCRM’s Commercial Review Committee / McMaster University / Pfizer-CCRM Innovation Fund / Lund Stem Cell Center in Sweden / Sick Children Research Institute / Industry Consortium / Directors and Commercialization Review Committee / King’s College / Queen’s University / University of Toronto / University of British Columbia / Ottawa Hospital Research Institute / University of Stirling / Stanford / /

Person

Kamal Garcha / Gary Skarja / Jennifer Moody / Stefan Karlsson / Elizabeth Gray / Robert Shaw / Michael May / Tony Pawson / Michael Rudnicki / James Ellis / Nick Timmins / Knut Niss / Wanyi Xiang / Allison Brown / Susan Runciman / Rahul Sarugaser / Stephen Minger / Mick Bhatia / Bernard Prigent / Cell Reprogramming / Emily Titus / Stacey Johnson / /

/

Position

Business Development Manager / Manager / Technology Development / Global Head of Research and Development / CEO / commercial director / and CEO / Lecturer and Director / development technologist / scientist / Commercial Director / Medical Director / Pfizer Canada / high-profile advocate / Director / co-founder and Director of the London Regenerative Medicine Network / Manager R&D / VP and Medical Director / senior scientist / Manager / Communications / /

ProvinceOrState

British Columbia / Massachusetts / /

Technology

cell therapy / cell-based technologies / stem cells / drug screening / drug discovery / Biomaterials / cell signaling / 4 technologies / Gene Therapy / biomaterials technology / RM technologies / regenerative medicine / /

URL

www.ccrm.ca/stephenminger / http /

SocialTag